The study found that inadvertent exposure to GLP-1s in early pregnancy was associated with a higher risk of the baby being born before 37 weeks when the drugs were used for diabetes treatment, but not among those taking them for weight loss
Pharmacists must adapt their communication style and content accordingly, often within the same workflow
This usually improves as their body adjusts to treatment
- Take one capsule daily with food
Anyone handling retatrutide whether as a clinical trial participant or healthcare professional must follow the Investigational Medicinal Product (IMP) label, the trial manual, or the dispensing pharmacist's instructions, and must not use the product beyond its labelled expiry date
Retatrutide targets GLP-1, GIP, and glucagon pathways to reduce appetite, boost metabolism, and support energy, promoting weight loss and overall metabolic health